| Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma F Ahmad, D Dixit, V Sharma, A Kumar, SD Joshi, C Sarkar, E Sen Cell death & disease 7 (5), e2213-e2213, 2016 | 116 | 2016 |
| Integrating molecular subclassification of medulloblastomas into routine clinical practice: a simplified approach K Kaur, A Kakkar, A Kumar, S Mallick, PK Julka, D Gupta, A Suri, V Suri, ... Brain Pathology 26 (3), 334-343, 2016 | 81 | 2016 |
| Telomerase reverse transcriptase (TERT)‐enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma F Ahmad, S Patrick, T Sheikh, V Sharma, P Pathak, PB Malgulwar, ... Journal of neurochemistry 143 (6), 671-683, 2017 | 58 | 2017 |
| Genome‐wide small noncoding RNA profiling of pediatric high‐grade gliomas reveals deregulation of several mi RNA s, identifies downregulation of sno RNA cluster HBII‐52 and … P Jha, R Agrawal, P Pathak, A Kumar, S Purkait, S Mallik, V Suri, ... International journal of cancer 137 (10), 2343-2353, 2015 | 53 | 2015 |
| PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications E Mohamed, A Kumar, Y Zhang, AS Wang, K Chen, Y Lim, A Shai, ... Neuro-oncology 24 (9), 1471-1481, 2022 | 39 | 2022 |
| Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma S Nayak, M Aich, A Kumar, S Sengupta, P Bajad, P Dhapola, D Paul, ... Scientific reports 8 (1), 1-10, 2018 | 35 | 2018 |
| Loss-of-function mutations in Calcitonin receptor (CALCR) identify highly aggressive glioblastoma with poor outcome J Pal, V Patil, A Kumar, K Kaur, C Sarkar, K Somasundaram Clinical Cancer Research 24 (6), 1448-1458, 2018 | 34 | 2018 |
| Genetic alterations related to BRAF‐FGFR genes and dysregulated MAPK/ERK/m TOR signaling in adult pilocytic astrocytoma P Pathak, A Kumar, P Jha, S Purkait, M Faruq, A Suri, V Suri, MC Sharma, ... Brain pathology 27 (5), 580-589, 2017 | 33 | 2017 |
| Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas A Kumar, P Pathak, S Purkait, M Faruq, P Jha, S Mallick, V Suri, ... Cancer genetics 208 (3), 91-95, 2015 | 33 | 2015 |
| CXCL14 promotes a robust brain tumor-associated immune response in glioma A Kumar, E Mohamed, S Tong, K Chen, J Mukherjee, Y Lim, CM Wong, ... Clinical Cancer Research 28 (13), 2898-2910, 2022 | 30 | 2022 |
| Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs) A Kakkar, A Majumdar, A Kumar, M Tripathi, P Pathak, MC Sharma, V Suri, ... Epilepsy research 127, 141-151, 2016 | 30 | 2016 |
| ATRX in diffuse gliomas with its mosaic/heterogeneous expression in a subset S Purkait, CA Miller, A Kumar, V Sharma, P Pathak, P Jha, MC Sharma, ... Brain Pathology 27 (2), 138-145, 2017 | 28 | 2017 |
| Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas S Purkait, V Sharma, A Kumar, P Pathak, S Mallick, P Jha, MC Sharma, ... Experimental and molecular pathology 100 (2), 312-320, 2016 | 28 | 2016 |
| Clinicopathological and molecular characteristics of pediatric meningiomas S Battu, A Kumar, P Pathak, S Purkait, L Dhawan, MC Sharma, A Suri, ... Neuropathology 38 (1), 22-33, 2018 | 26 | 2018 |
| Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of … S Kumar, A Kakkar, V Suri, A Kumar, U Bhagat, MC Sharma, M Singh, ... Neurology India 62 (4), 376-382, 2014 | 26 | 2014 |
| Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas A Kumar, S Nayak, P Pathak, S Purkait, PB Malgulawar, MC Sharma, ... Journal of Neuro-oncology 139, 23-31, 2018 | 24 | 2018 |
| Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas K Kaur, A Kakkar, A Kumar, S Purkait, S Mallick, V Suri, MC Sharma, ... Journal of neuro-oncology 130, 423-430, 2016 | 24 | 2016 |
| Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors S Mallick, AK Gandhi, NP Joshi, A Kumar, T Puri, DN Sharma, KP Haresh, ... Indian journal of medical and paediatric oncology 36 (02), 99-104, 2015 | 23 | 2015 |
| Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors V Sharma, S Purkait, S Takkar, PB Malgulwar, A Kumar, P Pathak, V Suri, ... Brain tumor pathology 33, 117-128, 2016 | 19 | 2016 |
| Mechanisms of resistance to EGFR inhibition reveal metabolic vulnerabilities in human GBM. PJJ McKinney A, Lindberg OR, Engler JR, Chen KY, Kumar A, Gong H, Lu KV ... Mol Cancer Ther., 2019 | 17 | 2019 |